![]() | ![]() |
SCHOTT Pharma has developed the next generation of SCHOTT TOPPAC® infuse polymer syringes, a system designed to improve safety, efficiency, and sustainability in healthcare.
Developed with SCHOTT Pharma's Alliance to Zero partners, Schreiner MediPharm and Körber Pharma, the system consists of a new cap, a functional label, and a carton packaging. This innovative solution addresses critical challenges hospitals face, including high levels of medication waste, inefficient manual processes, and storage constraints. It also improves patient safety and sustainability of the entire value chain.
"With our next-generation polymer syringe system, we are setting a new standard in the pharmaceutical industry by providing a solution that ensures drug stability, improves operational efficiency, and reduces precious drug and packaging waste," said Andreas Reisse, CEO of SCHOTT Pharma.
"Our collaboration with Schreiner MediPharm and Körber Pharma has enabled us to create a product that truly meets the needs of our customers, healthcare providers, and patients alike." The new generation of SCHOTT TOPPAC® infuse polymer syringes will be presented at the Pharmapack tradeshow from January 22 – 23 in Paris, France,” added Reisse.
SCHOTT Pharma's next generation SCHOTT TOPPAC® infuse prefillable polymer syringes are designed to streamline hospital processes from pre-op to inventory by reducing manual preparation steps and minimizing medication errors.
At the heart of the new syringe system is a pre-assembled cap that simplifies the filling process for pharmaceutical companies. The next generation of SCHOTT TOPPAC® infuse syringes can be filled on existing filling lines without requiring modifications or additional investment. Combined with a functional label, the new design covers the syringe shoulder completely, providing a first-opening indication for each syringe.
With conventional syringe systems, the first-opening mark can only be found on the secondary packaging. However, when provided directly at the point of use, the syringe can be re-used if it has not been previously opened. Combined with the high-quality cyclic olefin copolymer (COC) material used to manufacture SCHOTT TOPPAC® infuse, the new syringe system ensures drug stability throughout its shelf life, thus reducing the risk of drug contamination.
The new cap design allows for a functional label that provides additional protection, such as oxygen and light protection, but can also contain relevant information about the specific medication, such as expiration date or batch number. These can be digitalized by integrating them into the label with an RFID chip, enabling an automated, more efficient medication inventory process.
"An RFID chip in the label reduces the preparation time of an anesthesia tray, for example, from 20 minutes to just two minutes, significantly increasing operational efficiency. Moreover, the label-integrated RFID chip enables a digital first-opening indication," explained Dr. Nadine Lampka, Senior Product Manager Pharma-Security at Schreiner MediPharm.
While traditional secondary packaging for prefilled polymer syringes consists of a polymer blister, the new cap and label features provide the basis for a blister-free package, while allowing for a first-opening indication, maintaining the integrity of the prefilled syringe and protecting against mechanical impact or dust. This allows the use of cartons instead of polymer blisters, which are easier to open for nurses and doctors, less space-consuming for disposal, and easier to recycle.
The new SCHOTT TOPPAC® infuse prefillable polymer syringe system also accelerates time-to-market for pharmaceutical companies. SCHOTT Pharma's expertise in regulatory and analytical testing accelerates product development and enables pharmaceutical companies to meet industry requirements with confidence. In addition, they can continue to use existing data collected with the syringe, as only the closure has changed, simplifying the transition process.
Available in 3, 5, and 10ml volumes, the next generation of SCHOTT TOPPAC® infuse polymer syringes are set to revolutionize the healthcare industry by providing a more efficient, stable, and sustainable solution for drug delivery.
Last news about this category
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy